Report overview
TNF inhibitors are drugs that help stop inflammation. They're used to treat diseases like rheumatoid arthritis (RA), juvenile arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, ulcerative colitis (UC), and Crohn's disease.They're also called TNF blockers, biologic therapies, or anti-TNF drugs.
This report contains market size and forecasts of Tumor Necrosis Factor (TNF) Inhibitor Drugs in global, including the following market information:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Tumor Necrosis Factor (TNF) Inhibitor Drugs companies in 2021 (%)
The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Remicade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tumor Necrosis Factor (TNF) Inhibitor Drugs include Takeda Pharmaceuticals, Amgen, AbbVie, Pfizer, Novartis, Johnson and Johnson, UCB, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Necrosis Factor (TNF) Inhibitor Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Type, 2021 (%)
Remicade
Humira
Cimzia
Simponi
Others
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Application, 2021 (%)
Online Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues share in global market, 2021 (%)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceuticals
Amgen
AbbVie
Pfizer
Novartis
Johnson and Johnson
UCB
Merck
Abbott Laboratories
Biogen
Gilead Sciences
Thermo Fisher Scientific
Bristol-Myers Squibb
Astellas Pharma
AstraZeneca
Eli Lilly and Company
Roche
Sanofi
